...
首页> 外文期刊>American Journal of Surgical Pathology >Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis.
【24h】

Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis.

机译:Langerhans细胞组织细胞增生症中克隆淋巴样受体基因重排的检测。

获取原文
获取原文并翻译 | 示例
           

摘要

Langerhans cell histiocytosis (LCH), also known as histiocytosis X, is a rare human disorder characterized by an abnormal accumulation and/or clonal proliferation of Langerhans cells (LCs) in various body organs. The cellular origin of LCs has been a subject of considerable debate since their discovery. As specialized dendritic cells strategically located in epithelia, LCs are generally considered to be of myeloid origin from the bone marrow, however, recent studies in mice have shown that LCs can be derived from lymphoid-committed CD4 precursors, suggesting a lymphoid origin. In human LCH, concomitant or sequential occurrence of a lymphoid or myeloid malignancy has been occasionally reported, suggesting the presence of lineage plasticity and/or the possibility of transdifferentiation of 2 otherwise morphologically and immunophenotypically different neoplasms. To gain a better understanding of the pathogenesis and cellular origin of human LCH, we retrospectively investigated 46 well-characterized LCH cases to detect clonal rearrangements of T-cell receptor gamma gene (TRG@) and immunoglobulin heavy chain and kappa light chain genes (IGH@/IGK@). The study included 25 males and 21 females, with ages ranging from <1 to 59 years. None (0/46) of the cases had a known history or concurrent B or T-cell lymphoma. Of 46 cases, 30% (14/46) cases had clonal IGH@ (4 cases), IGK@ (5 cases) or TRG@ (9 cases) gene rearrangements, respectively. Interestingly, of the 14 cases with at least one clonal rearrangement of lymphoid receptor genes, 3 LCH cases were shown to have both TRG@ and IGH@/IGK@ gene rearrangements, but failed to express T-cell or B-cell lineage specific or associated markers, suggesting lineage plasticity or infidelity of the neoplasm. Furthermore, all of the 14 cases were negative for t(14;18) by quantitative PCR analysis. In conclusion, our study shows that lymphoid receptor gene rearrangements can be detected in a subset of sporadic LCH cases, suggesting a possible lineage relationship between LCs and lymphoid cells or alternatively, derivation of LCs from lymphoid/myeloid precursors. The results provide genotypic evidence supporting the current notion of lineage plasticity of hematopoietic cells and their associated neoplasms.
机译:朗格汉斯细胞组织细胞增生症(LCH),也称为组织细胞增生症X,是一种罕见的人类疾病,其特征是朗格汉斯细胞(LCs)在各种身体器官中异常积累和/或克隆增殖。自发现以来,LC的细胞起源一直是一个颇有争议的话题。由于战略性地位于上皮细胞的专门树突状细胞,LC通常被认为是来自骨髓的髓样来源,但是,最近在小鼠中的研究表明,LC可以衍生自淋巴样CD4前体,提示淋巴样起源。在人类LCH中,偶尔有淋巴样或髓样恶性肿瘤的伴随或相继发生,这表明存在谱系可塑性和/或2种在形态和免疫表型上不同的赘生物发生转分化的可能性。为了更好地了解人类LCH的发病机理和细胞起源,我们回顾性研究了46个特征明确的LCH病例,以检测T细胞受体γ基因(TRG @)和免疫球蛋白重链和κ轻链基因(IGH)的克隆重排。 @ / IGK @)。该研究包括25位男性和21位女性,年龄范围从<1到59岁。没有(0/46)病例有已知病史或并发B或T细胞淋巴瘤。在46例中,分别有30%(14/46)的患者发生了克隆IGH @(4例),IGK @(5例)或TRG @(9例)基因重排。有趣的是,在14个淋巴样受体基因发生至少一个克隆重排的病例中,有3个LCH病例显示出TRG @和IGH @ / IGK @基因重排,但未表达T细胞或B细胞谱系特异性或相关标记,提示肿瘤的谱系可塑性或不忠。此外,通过定量PCR分析,所有14例t(14; 18)均为阴性。总之,我们的研究表明,在一部分散发性LCH病例中可以检测到淋巴样受体基因重排,提示LC和淋巴样细胞之间可能存在谱系关系,或者从淋巴/髓样前体衍生LC。结果提供了基因型证据,支持了造血细胞及其相关肿瘤的谱系可塑性的当前观念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号